EPHB2 acts as EPHB2, a suppressor of prostate cancer cells, is able to exert its tumor suppressive effect by inhibiting the activity of lipogenic factors DGAT1, DGAT2 and promoting the lipolytic factor ATGL, PEDF (7). Here, DGAT1 is linked to prostate cancer.